t
,
6– 13, 14
t
– 15
t
outcomes over time, 13,
16– 17
t
, 18– 25
training in IPT for PTSD, 142– 44
IPT- PTSD handout (for patient), 64, 66,
119, 139,
147– 50
IPT sessions
audiotaping, 2, 12, 47, 94,
138– 39, 142– 44
scheduling, 44, 63, 129, 138
structure of, 71– 77
opening gambit, 71
IPT workshops, attending, 143
Kardiner, A., 1
Klerman, Gerald L., 36– 38
Krupnick, J. L., 4, 5
t
, 6
life events, ix.
See also
complicated grief/
complicated bereavement; trauma
feelings and symptoms as connected
to, 148
interactions between mood/ emotions
and, 38
f
, 38– 42, 65, 76, 78, 148
IPT and, 7, 37– 40, 45, 54, 65, 70, 76,
78, 148
and PTSD, 7, 45, 54, 65, 70, 148
Lovell, Karina, 11– 12
maintenance treatment, 46, 124– 29
major depression/ major depressive
disorder.
See also
depression
IPT for, xi, 7, 23, 36– 41, 47, 105, 127,
128, 132, 143, 147
pharmacotherapy for, 37, 42, 43
PTSD contrasted with, 48– 49
PTSD patients with comorbid
case material, 79– 81, 85– 87, 93– 97,
100– 102, 105, 118, 120
and dropout, 18– 20, 20
t
, 22, 23
IPT for, xi, 7, 8, 11, 18, 19, 22, 23, 56,
68, 134
prevalence of, 13, 15
t
, 32, 134
and treatment outcome, xi, 7, 18– 20,
20
t
, 23, 134
social support and, 41
symptoms of, 33, 70
life events and, 37– 39
medical model.
See
PTSD: as a medical
illness; treatability of PTSD
medication.
See also
pharmacotherapy
deciding whether or not to
prescribe, 42
middle phase of IPT, 44– 46, 68– 70,
78.
See also
IPT sessions;
specific topics
military PTSD, 29
mistrust.
See also
paranoid personality
disorder
of environment, 4, 50, 51, 87, 134
of people, 4, 87, 96, 134
mood.
See under
life events
9/ 11 terrorist attacks, 2, 80, 85, 86, 99– 105
normalization of affect, 44, 49, 64– 66,
70, 72, 73, 78.
See also
anger: validating and normalizing
case material, 83, 86, 91, 92, 94, 97,
111– 12, 121
164 I n D E x
options, recognizing and exploring
(alternative), 73– 74, 76– 77
paranoid personality disorder, 13, 15
t
, 21,
87– 88, 93, 134
Parsons, Talcott, 37– 38
personality disorders, 13, 21, 22, 87.
See
also
avoidant personality disorder;
paranoid personality disorder
pharmacotherapy
IPT and, 42, 134– 35
for major depression, 37, 42, 43
for PTSD, 3, 6, 15
t
, 22– 24, 42– 43, 46,
64, 67
t
, 127
efficacy of, 33– 35
posttraumatic stress disorder.
See
PTSD
present, focusing on the, 148
progress note, writing a, 43, 45, 50, 59,
136, 139, 140, 150
Prolonged Exposure (PE), x
description and overview of, 2
effects of IPT vs., 10– 13, 12
f
, 14
t
– 17
t
,
18– 20, 20
t
, 21
f
, 22– 26, 134
effects of Relaxation Therapy vs.,
10– 13, 12
f
, 14
t
– 17
t
, 18– 20, 20
t
,
21
f
, 22– 25
IPT compared with, 47
pharmacotherapy combined with, 35
psychodynamic interventions, 140
psychoeducation, 66– 67
PTSD (posttraumatic stress disorder), x.
See also specific topics
assessment of, 32– 33
diagnosis of, 29, 32– 33, 56– 61
DSM5 symptom criteria, 29, 30– 31
t
differential diagnosis of, 32
as a medical illness, 147, 148.
See also
treatability of PTSD
nature of, 27– 35, 147, 148
prevalence of, 27
subtypes of, 29
symptoms of, 3– 4, 67
theories regarding, 2– 4
treatment of, x– xi, 147– 48
practical difficulties the, 130– 36
treatment planning, 33– 35
prescriptions: things to do, 138– 39
proscriptions: things not to
do, 139– 41
PTSD patients.
See also specific topics
clinical characteristics of, 13, 15
t
demographic characteristics of, 13, 14
t
information therapist will want to
know about, 148– 49
IPT- PTSD handout for, 139, 147– 50
reassuring them of the treatability of
PTSD, 33, 38, 48, 57, 67, 147, 148
treatment preferences and
disinclinations of, 20, 21
f
reflection, 43, 73, 141, 146
reflective function, 53– 54
symptom- specific, 54, 146
reinforcement, providing, 32, 46, 66– 67,
71, 73– 76, 126
relationships.
See also
interpersonal
inventory
focus of IPT on current, 52
renegotiating them into a fairer
balance, 45, 69– 70, 106, 120,
123, 135
Relaxation Therapy (RT), effects of,
10– 13, 12
f
, 14
t
– 17
t
, 18– 20, 20
t
,
21
f
, 22– 25
reliving trauma, 150
revictimization, 4, 8, 121,
135– 36
risk taking and taking “safe risks,” 62, 73,
75– 76, 85, 114, 117, 123, 126, 149
role disputes, 39, 41, 44– 46, 54, 58– 60,
68– 70, 72, 77, 94, 96, 98,
106– 24
,
135, 142, 149
case examples, 94– 98, 106– 24
finding potential, 58– 59
goal of treating, 45
role play, 41, 44, 69– 70,
74– 77
, 126, 136, 143
case material, 84– 85, 91– 92, 96– 97, 103,
112– 13, 115, 118, 121– 23
role transition(s), 39, 44, 45, 54, 59, 60,
66– 70, 75, 77, 79, 81, 94, 96, 98,
117, 124, 135, 140, 149
case examples, 79– 105, 117
iatrogenic, 51
I n D E x 165
sadness, 42, 44, 46, 49, 65, 72– 73, 126.
See also
complicated grief/
complicated bereavement; grief
case material, 86, 102, 105, 111– 12
during termination, 46, 86, 126
“safe risks,” taking.
See
risk taking and
taking “safe risks”
secure attachment, 51, 53, 58– 59, 120
self- assertion, 41, 44, 57, 59, 61, 66, 69, 74,
85, 96, 106, 113, 126, 135
self- blame
depression and, 33, 38, 40, 42
PTSD and, 31
t
, 33
reminding patients that PTSD is not
their fault, 33, 38, 48, 57, 62– 63,
147, 148
separation, 46.
See also
termination
phase of IPT
September 11 attacks, 2, 80, 85,
86, 99– 105
sick role, 62, 96
social functioning.
See also
interpersonal
functioning
trauma and, 52
social skills, building, xi, 24, 41, 45, 69, 78
social support, xi, 7, 23, 28, 41, 43, 57– 59,
70, 103, 117– 18, 127, 131, 145, 150.
See also
interpersonal inventory
mobilizing/ finding potential, 41,
45– 46, 50– 53, 58, 150
Spiegel, H., 1
stress- diathesis model, 38
substance abuse/ dependence, 12
f
, 15
t
, 19,
32, 57, 94, 130,
Do'stlaringiz bilan baham: |